The baseline information including tumor diameter, tumor stage, type of surgery, chemotherapy, lymph node metastases, peritumoral vascular invasion, ER/PR positivity, HER-2, and Ki-67, was compared between the high RDW group and the low RDW group. The gene discussed is PGR; the disease is metastatic malignant neoplasm in the lymph nodes.